The global diabetic retinopathy market is estimated to grow at a CAGR of over 6% during the forecast period. The market growth is attributed to the increasing geriatric population coupled with the increasing prevalence of retinal disorders across the globe and the presence of robust product pipeline for retinal disorder treatment products.
Geographically, the report on the global retinal disorders treatment industry is segmented into North America, Europe, Asia-Pacific and the Rest of the World. North America is projected to dominate the market, owing to the increasing healthcare expenditure in the US and the presence of well-developed healthcare infrastructure in the country. The regional market is also driven by factors such as the increasing prevalence of ophthalmic disorders and increasing regulatory approvals for several treatment drugs.
Browse the full report description of "Global Retinal Disorders Treatment Market Size, Share & Trends Analysis Report by Disease Type (Floaters, Macular Degeneration, Diabetic Eye Disease, Retinal Detachment, and Others), By Dosage Form (Gels, Eye Solutions, Tablets and Capsules, Ointments, and Others), and Forecast 2019-2025" at https://www.omrglobal.com/industry-reports/retinal-disorders-treatment-market
Further, there are several organizations such as the American Optometric Association, International Eye Foundation, and Diabetic Eye Care, among others in the region that works on the development of various drugs and treatment techniques for improving the sight vision of people. The American Academy of Ophthalmology is also focused on protecting sight and empowering lives by serving as an advocate for patients and the public, leading the ophthalmic education. Thus, the presence of such organizations is likely to promote the growth of the regional share of the retinal disorder treatment market.
Whereas, Asia-Pacific is also projected to be a key shareholding region and is estimated to exhibit a remarkable growth during the forecast period. The regional growth is attributed to the contribution of the major economies includingChina, Japan, and India. Increasing FDA approval in the regional marketplace spurs the growth of the retinal disorders treatment industry in Asia-Pacific. Also, the increased prevalence of retinal disorders in the region is propelling the growth of the market.
Furthermore, in the European region, the rising prevalence of diabetes is encouraging market growth. According to International Diabetes Federation (IDF) Europe in 2018, 425 million people were having diabetes across the globe, among which,more than 58 million people were from Europe,and this number of European populations will rise to 66.7 million by 2045. In 2017, the European Diabetes Study investigated patients from 31 centers in 16 European countries. The overall mean prevalence of diabetic retinopathy in 3,250 type-1 diabetes patients was 35.9%. A significant increase in the number of diabetic retinopathy cases will lead to the growing demand for treatments in the region and hence will expand the overall retinal disorders treatment market size.
Global Retinal Disorders Treatment Market – Segmentation
By Disease Type
By Drug Dosage Form
Global Retinal Disorders Treatment Market – Segmentation by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/retinal-disorders-treatment-market